XENETIC BIOSCIENCES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $18.4M | $18.2M |
| FY2022 | — | $13.6M | $13.1M |
| FY2023 | — | $9.8M | $9.0M |
| FY2024 | — | $6.0M | $6.2M |
| FY2025 | — | $7.4M | $7.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $18.4M | $18.2M |
| FY2022 | — | $13.6M | $13.1M |
| FY2023 | — | $9.8M | $9.0M |
| FY2024 | — | $6.0M | $6.2M |
| FY2025 | — | $7.4M | $7.9M |